Visualization of GFP-Sla1 in yeast and hyphal cells of GZY707 (sla1∆/P MET3 -GFP-SLA1). (B) Visualization of GFP-Sla1 and Act1-mCherry in yeast and hyphal cells of GZY752 (sla1∆/P MET3 -GFP-SLA1 ACT/ACT1-mCherry). Cells were either grown in GMM at 30°C, or induced for hyphal formation by incubating with 20% FBS at 37°C for several hours. Samples were taken at the indicated time points and cells were fixed with Stopmix before microscopic visualization. Note that Act1-mCherry is not fully functional in vivo and results in abnormal hyphal morphology. Figure S3 . Actin cytoskeleton organization and LY uptake in sla1∆/∆ cells. (A and B) Direct visualization of actin cytoskeleton in the sla1∆/∆ cells during yeast (A) and hyphal growth (B). WT (GZY730) and sla1∆/∆ (GZY733) cells expressing Lifeact-GFP were either grown in GMM at 30°C or induced for hyphal growth with 20% FBS at 37°C for 1 to 2 h. Cells were fixed with Stopmix for microscopy. (C) LY uptake of the sla1∆/∆ cells. WT (BWP17) and sla1∆/∆ (GZY602) cells were grown in GMM at 30°C and incubated with LY for 20, 40, and 60 min, respectively. Cells were washed with PBS and examined for LY uptake. Hyphal morphology of the sla1 C-terminal truncated mutants. Cells of SLA1-WT (GZY652), sla1-∆C502 (GZY625), sla1-∆C385 (GZY629), and sla1-∆C64 (GZY639) were grown in YPD at 30°C and induced for hyphal growth by incubation with 20% of FBS at 37°C. Samples were taken at 1-h intervals upon hyphal induction for morphological examination.
Movie 01. Live cell imaging of Lifeact-GFP in BWP17 (GZY730) yeast cells.
Movie 02. Live cell imaging of Lifeact-GFP in sla1∆/∆ (GZY733) yeast cells.
Movie 03. Live cell imaging of Lifeact-GFP in BWP17 (GZY730) hyphal cells.
Movie 04. Live cell imaging of Lifeact-GFP in sla1∆/∆ (GZY733) hyphal cells.
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pYGS829
CLN3c-Myc-UTR/CIP10U; DNA fragment encoding Cln3 (268-465 aa) was cloned in frame with a C-terminal 6xMyc epitope (followed by UTR, the 3' untranslated region of CaGAL4) into CIP10U. The plasmid was linearized by BamHI within CLN3 for integration to generate CLN3-Myc-URA3.
pYGS837
GST-CLN3; DNA fragment encoding Cln3 (1-465 aa) was cloned into pGEX-4T-1.
pYGS859
SLA1c-HA-UTR/CIP10U; DNA fragment encoding Sla1 (658-1257 aa) was cloned in frame with a C-terminal 2xHA epitope (followed by UTR) into CIP10U. The plasmid was linearized by XcmI within SLA1 for integration to generate SLA1-HA-URA3.
pYGS861 CLN3ΔURA3-FLP/pBKS; CLN3 promoter region (-556 to -1 bp) and terminator region (1399 to 1773 bp) were cloned to flank the CaURA3 flipper in pBKS vector. The knockout cassette was released by KpnI and SacII for transformation to generate cln3Δ::FRT.
pYGS868 SLA1ΔURA3-FLP/pBKS; SLA1 promoter region (-509 to -1 bp) and terminator region (3775 to 4240 bp) were cloned to flank the CaURA3 flipper in pBKS vector. The knockout cassette was released by KpnI and SacII for transformation to generate sla1Δ::URA3-FLP and sla1Δ::FRT. pYGS870 SLA1ΔARG4/pBKS; CaURA3 flipper in pYGS868 was replaced with CaARG4. The knock-out cassette was released by KpnI and SacII for transformation to generate sla1∆::ARG4.
pYGS877 CLN3ΔARG4-P MET3 -Myc/pTEZ; CLN3 promoter region (-444 to -1 bp) and coding region (1 to 500 bp) were cloned to flank ARG4-P MET3 -Myc (CaARG4 followed by 6xMyc epitope under CaMET3 promoter control) in pTEZ vector. The knock-in cassette was released by KpnI and SacII for transformation to generate P MET3 -Myc-CLN3-ARG4.
pYGS893
SLA1c-HA-UTR/CIP10A; CaURA3 in pYGS859 was replaced with CaARG4. The plasmid was linearized by XcmI within SLA1 for integration to generate SLA1-HA-ARG4.
pYGS894 SLA1ΔC502-HA-UTR/CIP10U; DNA fragment encoding Sla1 (457-755 aa) was cloned in frame with a C-terminal 2xHA epitope (followed by UTR) into CIP10U. The plasmid was linearized by SalI within SLA1 for integration to generate SLA1ΔC502-HA-URA3.
pYGS895 P GAL1 -HA-SLA1n/CIP10U; DNA fragment encoding Sla1 (1-304 aa) was cloned in frame with an N-terminal 2xHA epitope (under CaGAL1 promoter control) into CIP10U. The plasmid was linearized by BsaBI within SLA1 for integration to generate P GAL1 -HA-SLA1-URA3.
pYGS896 SLA1ΔC385-HA-UTR/CIP10U; DNA fragment encoding Sla1 (457-872 aa) was cloned in frame with a C-terminal 2xHA epitope (followed by UTR) into CIP10U. The plasmid was linearized by SalI within SLA1 for integration to generate SLA1ΔC64-HA-URA3.
pYGS913 SLA1ΔC64-HA-UTR/CIP10U; DNA fragment encoding Sla1 (658-1193 aa) was cloned in frame with a C-terminal 2xHA epitope (followed by UTR) into CIP10U. The plasmid was linearized by XcmI within SLA1 for integration to generate SLA1ΔC385-HA-URA3.
pYGS920 Pro-SLA1-WT-HA-UTR/CIP10U; DNA fragment containing SLA1 promoter and coding region (-1000 to 3771 bp) was cloned in frame with a C-terminal 2xHA epitope (followed by UTR) into CIP10U. The plasmid was linearized by PmeI (generated by mutagenesis at promoter region -550 bp) for integration to generate SLA1-WT-HA-URA3.
pYGS924
Pro-sla1-13A-HA-UTR/CIP10U; pYGS920 was used as the template for mutagenesis to introduce 13 mutations (T181A, S194A, T201A, T611A, S690A, T720A, S757A, T767A,  S800A, T805A, T865A , S1194A, T1250A) on Sla1. The plasmid was linearized by PmeI for integration to generate sla1-13A-HA-URA3.
pYGS929
Pro-sla1-13E-HA-UTR/CIP10U; pYGS920 was used as the template for mutagenesis to introduce 13 mutations (T181E, S194E, T201E, T611E, S690E, T720E, S757E, T767E, S800E, T805E, T865E, S1194E, T1250E) on Sla1. The plasmid was linearized by PmeI for integration to generate sla1-13E-HA-URA3.
pYGS964 P MET3 -GFP-SLA1n/CIP10U; DNA fragment encoding Sla1 (1-304 aa) was cloned in frame with an N-terminal GFP epitope (under CaMET3 promoter control) into CIP10U. The plasmid was linearized by BsaBI within SLA1 for integration to generate P MET3 -GFP-SLA1-URA3.
pYGS965 P MET3 -GFP-SLA1n/CIP10H; CaURA3 in pYGS964 was replaced with CaHIS1. The plasmid was linearized by BsaBI within SLA1 for integration to generate P MET3 -GFP-SLA1-HIS1.
pYGS968
PAN1c-Myc-UTR/CIP10U; DNA fragment encoding Pan1 (800-1397 aa) was cloned in frame with a C-terminal 6xMyc epitope (followed by UTR) into CIP10U.
pYGS970
PAN1c-Myc-UTR/CIP10H; CaURA3 in pYGS968 was replaced with CaHIS1. The plasmid was linearized by HindIII within PAN1 for integration to generate PAN1-Myc-HIS1.
pYGS971
Pro-SLA1 23E -HA-UTR/CIP10U; pYGS929 was used as the template for mutagenesis to introduce 10 mutations (T869E, T878E, T887E, T905E, T915E, T923E, T1002E,  T1022E , T1226E, T1240E) on Sla1-13E. The plasmid was linearized by PmeI for integration to generate SLA1 23E -HA-URA3.
pYGS972
ACT1c-mCherry-TADH1/CIP10U; DNA fragment encoding Act1 (4-376 aa, including 367 bp intron region) was cloned in frame with a C-terminal mCherry epitope (followed by CaADH1 terminator) into CIP10U. The plasmid was linearized by ClaI within ACT1 for integration to generate ACT1-mCherry-TADH1-URA3.
pYGS974
TEF1ΔLifeAct-GFP-HIS1/pJET; DNA fragment amplified from pFA-GFP-CaHIS1 with the primer pairs Lifeact S1 (5'-atcttgatttttacttcttcttcttcttcttctttttcctttcttcacacattatagtcataa tcaatcatgggtg tcgcagatttgatcaagaaattcgaaagcatctcaaaggaagaaggtgctggcgcaggtgcttc-3') and LifeAct S2 (5'-taagaaaataaactaaataaatgaatacaaaataaaaactctaacagatcttacataatatt caactagctctgatatcatcgatgaattcgag-3') was cloned into pJET vector. The knock-in cassette was released by NotI and XbaI for transformation to generate P TEF1 -LifeAct-GFP-HIS1. pYGS983 PRK1ΔHIS1/pTEZ; PRK1 promoter region (-499 to -1 bp) and terminator region (2073 to 2472 bp) were cloned to flank CaHIS1 in pTEZ vector. The knock-out cassette was released by NotI for transformation to generate prk1Δ::HIS1. pYGS985 PRK1ΔARG4/pTEZ; CaHIS1 in pYGS983 was replaced with CaARG4. The knock-out cassette was released by NotI for transformation to generate prk1Δ::ARG4.
pYGS987 P MET3 -ARN1-GFP-UTR/CIP10U; DNA fragment encoding Arn1 (1-604 aa) was placed under CaMET3 promoter control and cloned in frame with a C-terminal GFP epitope (followed by UTR) into CIP10U. The plasmid was linearized by NsiI within P MET3 for integration to generate P MET3 -ARN1-GFP-URA3.
pYGS994 P MET3 -ARN1-GFP-UTR/CIP10H; CaURA3 in pYGS987 was replaced with CaHIS1. The plasmid was linearized by NsiI within P MET3 for integration to generate P MET3 -ARN1-GFP-URA3. 
